Zachary Berman

Zachary Berman and Kirema Garcia-Reyes, interventional radiologists, share their expertise on Y-90 dosimetry, stressing that it's not a one-size-fits-all approach. They discuss factors influencing dosing, such as tumor size and underlying liver function. The guests reflect on gaps in training and the evolution of dosimetry education in interventional radiology. Real-life case examples illustrate the complexities of individualized treatment plans. They also critique planning software and underscore the importance of empirical approaches to achieve optimal dosages.

Dr. Zachary Berman, a hepatobiliary interventional oncologist and Associate Clinical Professor of Radiology at UC San Diego, shares expertise on microwave ablation for hepatocellular carcinoma (HCC). He emphasizes a multidisciplinary approach, discussing the roles of tumor boards and collaborative care. Berman elaborates on pre-procedure imaging, the importance of ultrasound skills, and navigating complex cases. The conversation also touches on the integration of immunotherapy and advanced imaging techniques to enhance ablation outcomes.

In this engaging discussion, medical oncologists Adam Burgoyne and Lingling Du, alongside interventional radiologists Kirema Garcia-Reyes and Zachary Berman, tackle the complexities of hepatocellular carcinoma (HCC) treatment. They explore the 'grey zone' in treatment goals, emphasizing the importance of performance status and comprehensive liver function assessments. The guests share insights on navigating advanced liver disease, the role of immunotherapy, and the critical need for multidisciplinary collaboration to optimize patient outcomes.